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SUMMARY
The basidiomycetous yeast Cryptococcus neoformans is an important fungal pathogen mainly in immunocompromised patients.
In this study, 47 clinical isolates of C. neoformans from regions of São Paulo State were studied serologically by using the Crypto
Check Iatron RM 304-K kit, their genetic diversity was estimated by PCR-fingerprinting with a microsatellite-specific sequence
(GACA)4, RAPD with primer 6 (Amersham Pharmacia Biotech), PCR-restriction fragment length polymorphism (RFLP) analysis
of the phospholipase B gene (PLB1) digested with AvaI and mating type analysis by PCR. All 47 strains isolated from HIV positive
patients included in this study were serotype A and MATα. The majority of the isolates (45/47) were VNI and only two were VNII
by PCR-fingerprinting and PCR-RFLP analysis. High degree of homogeneity was observed when (GACA)4 was used, being highly
correlated (> 0.9). In contrast, the RAPD analysis was more heterogeneous with higher number of molecular profiles. By PCR-
RFLP, no new molecular type was found, enhancing the suggestion that the differences based on conserved gene as PLB1, can be
resultant of ongoing divergent evolution within the C. neoformans complex, into the current eight subtypes. Our results furnish
new information on the molecular epidemiology of C. neoformans in the southeast region of Brazil.
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INTRODUCTION
Cryptococcus neoformans is an encapsulated yeast agent of human
and animal cryptococcosis30,31. This opportunistic fungal pathogen has
a worldwide distribution and is responsible for life-threatening
infections of the central nervous system, mainly in patients with
AIDS11,39. Two distinct species have been recognized: C. neoformans
with two varieties, var. grubii (serotype A), var. neoformans (serotype
D) and the hybrid serotype AD and C. gattii, including serotypes B
and C20,28.
Human infection is acquired by inhalation of infectious propagules
such as desiccated yeast cells or maybe basidiospores from environment
sources21,35,44. C. neoformans is a heterothallic basidiomycete that exists
as two mating types, α and a, being determined by single locus MAT,
with two alleles24 . One of the most interesting features of C. neoformans
is the imbalance between mating-types prevalence in the environmental
as well as clinical isolates. Almost all isolates have been found to be
mating-type α27. However, some rare isolates identified as MATα/a
are considered to be occasional diploid or aneuploid strains13,34.
Most infections, in immunocompromised hosts, are caused by C.
neoformans var. grubii11,39. In contrast, C. neoformans var. gattii
generally affects immunocompetent hosts43. The incidence of
cryptococcosis varies according to the population, the region and the
period studied. In Brazil, from 1980 to 2002, 215,810 AIDS patients
were registered, among whom 6% had cryptococcosis at the time of
diagnosis9 and São Paulo is the state with the highest rate of this disease.
The majority of the Brazilian clinical and environmental isolates have
shown to be serotype A with exception in north and northeastern regions
where the serotype B is endemic1,4,41,46.
Epidemiological studies on cryptococcosis are essential to
understand the biology of this fungus in order to improve current therapy
against this infection. Several molecular typing methods have been
used in epidemiological analyses of clinical and/or environmental
isolates of C. neoformans, including karyotyping, PCR fingerprinting,
random amplified polymorphic DNA (RAPD), restriction fragment
length polymorphism (RFLP) and amplified fragment length
polymorphism (AFLP)5,7,8,10,12,16,22,26,37,45. PCR-fingerprinting using mini
(M13) or microsatellite [(GACA)4] specific sequences as single primers
and RFLP (PLB1 and URA5 genes) methods have grouped global
isolates of C. neoformans into eight major molecular types32,37,38. Likely,
BOEKHOUT et al. using AFLP analysis grouped into six major AFLP
groups8. FRANZOT et al. using CNRE-1 RFLP analysis and URA5
sequencing found low genetic diversity among Brazilian isolates19;
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conversely, HORTA et al. have found great differences in RAPD
profiles23. On the other hand, ALMEIDA et al. showed the presence of
22 EK and 15 RAPD profiles that were highly related2.
Phospholipases are found in a wide range of organisms, including
both pathogenic and nonpathogenic species of yeasts and moulds6,15,33,36.
The phospholipase B (PLB1) gene of C. neoformans has been described
as important virulence factor in a mouse and rabbit and as interesting
target for molecular typing of C. neoformans via PCR-RFLP
analysis15,32. However until the present moment, there are not available
data about the molecular epidemiology of C. neoformans using PLB1-
RFLP method in Brazil.
Even though C. neoformans is a leading cause of life-threatening
mycotic infection among AIDS patients in Brazil, a small amount of
works have studied this molecular epidemiology. In light of this, we
analyzed clinical isolates of C. neoformans from several regions of
São Paulo State to evaluate serotypes, genetic variability using PCR-
fingerprinting with (GACA)4 oligonucleotide, RAPD with primer 6,
PLB1-RFLP and mating type analysis by PCR.
MATERIAL AND METHODS
Fungal isolates: Forty-seven strains of C. neoformans were isolated
at intervals; from thirty-five AIDS patients from São José do Rio Preto,
Santos, Araraquara and Ribeirão Preto, from various geographic areas
of São Paulo State, Brazil, during the pre-highly active antiretroviral
therapy (HAART) period. These isolates were maintained in the Culture
Collection of the Instituto Adolfo Lutz laboratory, a Public Health
National Reference Center, located in six different cities in São Paulo
State. The C. neoformans cultures were grown at 30 °C on Sabouraud
dextrose agar with chloramphenicol. The isolates were identified by
conventional methods to genus, species and variety. Serotyping was
performed by slide agglutination (Crypto Check Iatron kit, Tokyo,
Japan), following the manufacturer’s instructions.
DNA isolation: Genomic DNA was extracted and purified by a slight
modification of the method of DEL SAL et al.17. Briefly, C. neoformans
isolates were grown on Sabouraud’s dextrose agar at 30 °C for 48 hours
and two loopfuls of cells from the culture were suspended in YEPD
medium with 2.9% NaCl and then incubated at 30 °C overnight. Cells
were harvested and suspended in CES (20 mmol l-1 sodium citrate;
50 mmol l-1 EDTA pH 8.0; 0.9 mol l-1 sorbitol) containing Novozym 234
(NovoNordisk, from Trichoderma harzianum, Denmark). The suspension
was incubated at 37 °C for three hours, and spheroplasts were collected by
centrifugation. DNA was isolated by lysing the spheroplasts in TEN buffer
with 1% SDS (1 mol l-1 Tris-base; 0.5 mol l-1 EDTA; 1 mol l-1 NaCl; 1%
SDS). Chloroform-isoamyl alcohol (24:1) was then added, shaken and
centrifuged for 13 minutes at 12000 rpm and the aqueous phase was
transferred to a new tube. To precipitate the DNA, isopropanol (1:1) was
added and incubated at -20 °C for 30 minutes. The DNA pellet was washed
with 70% ethanol, centrifuged and air-dried. Finally, the DNA was
resuspended in 80 µL TE (40 mmol l-1 Tris-base, 2 mmol l-1 EDTA).
RAPD and PCR-fingerprinting: Oligonucleotides of the micro-
satellite-specific sequence (GACA)4 were used as single primers in the
PCR, as described by MEYER et al.38. The amplification reactions were
performed in a volume of 25 µL, using the Ready-to-Go RAPD Kit
according to the manufacturer’s instructions. PCR was performed for 35
cycles in a Perkin-Elmer Thermal cycler (model GeneAmp PCR System
9700), each consisting of with 20 seconds of denaturation at 94 °C, one
minute annealing at 50 °C, and 20 seconds extension at 72 °C, followed
by a final extension cycle for six minutes at 72 °C. Amplification products
were separated by electrophoresis on 2% agarose gels in 1X TBE buffer
(Tris-borate-EDTA) at 150V for 2.5 hours, stained with ethidium bromide
and then visualized under UV light.
The RAPD analysis was carried out using primer six
(5’CCCGTCAGCA-3’; Amersham Pharmacia Biotech) in a volume of
25 µL, using the Ready-to-Go RAPD Kit according to the manufacturer’s
instructions. The following cycle conditions were used: initial
denaturation at 95 °C for five minutes, followed by 45 cycles of
denaturation at 95 °C for one minute, annealing at 36 °C for one minute
and amplification at 72 °C for two minutes, and a final extension at
72 °C for 10 minutes. Amplification products were separated by
electrophoresis, on 2% agarose gels in 1X TBE buffer at 150V for 2.5
hours and stained with ethidium bromide and then visualized under UV
light.
PCR-RFLP analysis of the PLB1 gene: The PLB1 fragment was
amplified by PCR, in a final volume of 50 µL, digested with AvaI in
accordance with LATOUCHE et al.32 and was separated by
electrophoresis on 3% agarose gel at 100V for 5.5 hours.
Determination of mating type: Mating type was established by PCR
using two primer pairs, specific for mating-type α and a, in accordance
with CHATURVEDI et al.13. Initial denaturation was done at 95 °C for
three minutes, followed by 30 cycles of denaturation at 94 °C for one
minute, annealing at 57.5 °C for one minute, amplification at 72 °C for
one minute, and a final extension at 72 °C for seven minutes, in a
GeneAmp PCR System 9700 (Perkin-Elmer). Amplification products
were separated by electrophoresis on 2% agarose gels in 1X TBE buffer
at 120V for two hours stained with ethidium bromide and then
visualized under UV light.
Reference strains: The following C. neoformans standard reference
strains representing each major molecular type were used in PCR
fingerprinting and PCR-RFLP: WM148 (VNI - serotype A), WM626
(VNII - serotype A), WM628 (VNIII - serotype AD), WM629 (VNIV
- serotype D), WM179 (VGI - serotype B), WM178 (VGII - serotype
B), WM161 (VGIII - serotype B), WM779 (VGIV - serotype C)37.
The C. neoformans strains ATCC 28957 (serotype D, MATα) and
ATCC 28958 (serotype D, MATa) were used as positive control for
determination of mating type by PCR.
Statistical analysis: The computer software GelCompar II (Applied
Maths, Version 2.0, Belgium) was used to determine the genetic
relatedness of the isolates. Similarity coefficients were calculated by
using the Dice Algorithm and cluster analysis was performed by the
UPGMA (Unweighted Pair-Group Method Using Arithmetic Averages)
tree method.
RESULTS
Fungal isolates: A total of 47 cryptococcal isolates from four São
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Paulo State districts were recovered from 35 HIV-positive patients,
among whom nine (25%) had more than one sample taken at the time
of diagnosis and during the treatment and 27 (75%) provided single
samples. All isolates were identified as C. neoformans var. grubii,
serotype A.
Determination of Mating Type by PCR: The MATα and MATa
specific primers pair were used to amplify specific fragments of 101bp
and 117bp, respectively. Epidemiological analysis of the mating type
showed 100% prevalence of MATα in all four regions (Fig. 1).
PLB1-RFLP, PCR-fingerprinting and RAPD analysis: The PLB1-
RFLP and (GACA)4-PCR fingerprinting analysis were carried out to
separate the strains of C. neoformans into eight major molecular types
(Fig. 2A).
The RFLP profiles generated showed prevalence of 95.7% (45/47)
of the molecular type VNI and only two VNII (4.3%) (Fig. 2B).
Random primer 6 and a single primer specific to microsatellite
repeats (GACA)4 were used to amplify DNA polymorphisms within
the cryptococcal genome. RAPD profiles and PCR fingerprinting types
were assigned according to the major bands. For both (GACA)4 and
random primer 6, all visible and well-defined bands identified visually
and confirmed by the software were included in the analysis (Fig. 2B).
Similarity dendrogram analysis obtained with (GACA)4 showed a high
overall homogeneity among the 47 isolates from São Paulo State. The
mean coefficient similarity value of the strains was 0.98 ± 0.04. Two
major groups were formed. The group I, corresponding C. neoformans
var. grubii (VNI type strains), was clustered 45 isolates (95.7%) in
three profiles with similarity around 0.94. The second minor group
(II) with only two VNII type strains was formed showing correlation
of 0.84 with the VNI group (Fig. 3). In contrast, the dendrogram based
on RAPD profiles with primer 6 showed more heterogeneous profile.
The mean coefficient similarity of the strains was 0.84 ± 0.15. A total
of 14 profiles were distributed in three major groups that showed
similarity around 0.55. The group I had approximately 0.8 of similarity
and clustered 41 strains (87.2%) in 11 profiles, all molecular type VNI.
The two strains VNII were grouped in a distinct cluster (group II) as
obtained with (GACA)4 showing correlation around 0.7 with the group
I. Finally, the group III containing four isolates and two profiles included
strains from Santos and Araraquara districts that had 100% similarity
with PCR fingerprinting but when compared with RAPD showed a
low similarity coefficient (< 0.6) with the other two groups (Fig. 4).
DISCUSSION
The epidemiology of C. neoformans complex has been extensively
explored worldwide but in Brazil, specially in São Paulo State, the
data on molecular epidemiology remain scarce and more information
would help to elucidate the distribution of the major molecular types
among Brazilian isolates. The genetic structure of C. neoformans is
very complex and the employment of new primers in RAPD, as well
as other molecular tools, such as the PCR-RFLP method based on PLB1
gene in this work, are interesting and important to elucidate the
epidemiology. All isolates included in this study were recovered from
HIV-positive patients and identified as C. neoformans var. grubii,
serotype A. This finding is consistent with previous studies showing
that the majority of the cases of cryptococcosis in immunocompromised
hosts, mainly patients with AIDS, in Brazil as well as worldwide, are
caused by serotype A11,12,39,41. NISHIKAWA et al. serotyped 467 C.
neoformans isolates from clinical and environmental sources in Brazil.
Serotype A was more prevalent mainly in southern and southeast regions
while the serotype B was predominant in north and northeastern
region41.
Several typing approaches have been used in epidemiological
studies to characterize and investigate the genetic structure of C.
neoformans isolates. All C. neoformans isolates were grouped into
one major molecular type VNI (var. grubii, serotype A) with (GACA)4-
PCR fingerprinting and confirmed by PLB1-RFLP, with exception of
two strains that were identified as VNII, from Santos district. Our results
are similar to previous studies that found VNI type strains as the
commonest molecular type. An IberoAmerican study performed with
strains from nine countries including Brazil showed prevalence of VNI
among 340 C. neoformans strains. Specifically, 66 Brazilian strains
were included revealing only three molecular types being VNI more
predominant with 82.3% followed by VGII (13.6%) and VNII (3.0%)37.
CASALI et al., in an important survey of Brazilian cryptococcal isolates
from the southern region of the country, investigated 105 clinical and
19 environmental isolates and also verified a predominance of C.
neoformans var. grubii molecular type VNI12. Although with low
number of strains, the RAPD analysis showed notable heterogeneity.
While the (GACA)4 PCR fingerprinting yielded four profiles distributed
in two major groups with mean similarity value of 0.98 ± 0.04, the
primer 6 RAPD yielded 14 profiles in three major groups with mean
similarity of 0.84 ± 0.15 value. Moreover, four isolates that were high
similar with PCR-fingerprinting showed low correlation with primer
6. These results can have occurred because the primer probably
hybridizes with less conserved regions of the genomic DNA generating
more polymorphisms3. In a previous study, twenty two arbitrary
polymerase chain reaction primers were tested in clinical and
environmental isolates from the Brazilian state Rio Grande do Sul
among them eight confirmed the genetic polymorphism23. In another,
numerous distinguishable subtypes were identified among strains
recovered from AIDS patients26.
Nine patients investigated in this study had more than one sample
taken at the time of diagnosis and during the treatment. Almost all
serial isolates showed identical genotypes independent of the time of
isolation. Only one patient with two serial isolates had genotype variety
with primer 6 but not with (GACA)4. However the value of coefficient
similarity was > 0.9 suggesting that microevolution probably occurred.
The PCR-RFLP method based on PLB1 gene is of great importance
because highlights differences based on partial sequence of a single
virulence gene, while PCR-fingerprinting, on the other hand, amplifies
mostly noncoding DNA sequences across the whole genome14,32. In
our knowledge, there are not reports evolving Brazilian samples using
this method. The PLB1-RFLP was applied associated with PCR-
fingerprinting to differentiate the strains into eight molecular types
previously described as well as verify the possible existence of a new
molecular subtype. In the present work, VNI was prevalent in 45/47
isolates (95.7%) while VNII was 2/47 (4.3%), none new molecular
subtype was found. Our results enhance previous data that suggest the
differences based on more conserved genes as PLB1 or URA-5 by
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Fig. 1 - PCR amplification of C. neoformans isolates for determination of mating type. Lane 1, molecular weight marker (Gibco 100bp); 2, ATCC 28957 (MATα); 3, ATCC 28958 (MATa); 4-
7, clinical isolates; 8, negative control.
Fig. 2 - A. PCR fingerprinting with primer (GACA)4 (AI) and PLB1-RFLP with AvaI (AII) patterns of C. neoformans. Lane 1*, molecular weight marker; 2-5, molecular types VNI, VNII,
VNIII, VNIV; 6-9, molecular types VGI, VGII, VGIII, VGIV – B. Representative gel of (GACA)4-PCR fingerprinting (BI), Primer 6-RAPD (BII) and PLB1-RFLP (BIII) from clinical isolates
of C. neoformans. Lane 1*, molecular weight marker; 2-4, clinical isolates 377, 379 and 387 (molecular type VNI, serotype A); 5-6, clinical isolates 382 and 384 (molecular type VNII, serotype
A). * Molecular weight marker (Gibco 100bp) to the (GACA)4-PCR fingerprinting (AI and BI) and Primer 6-RAPD (BII). Molecular weight marker (Promega 100bp) to the PLB1-RFLP (AII
and BIII).
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Fig. 3 - Dendrogram of the PCR-fingerprinting patterns obtained from C. neoformans isolates
with primer (GACA)4.
Fig. 4 - Dendrogram of the RAPD patterns obtained from C. neoformans isolates with primer
6.
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PCR-RFLP can be resultant of ongoing divergent evolution within the
C. neoformans complex, into the current eight subtypes and not only
coincidental32.
Mating type α-specific primer was used here and yielded a 101bp
MATα fragment in all cases, showing that all C. neoformans isolates
were MATα, consistently with a previous study showing that MATα is
more frequent than MATa among clinical as well as environmental
isolates12,25,27,42. Information about the mating-types of C. neoformans
strains is important for an understanding of their ecology and virulence.
It has been reported that MATα is more virulent than the opposite type
MATa29. Moreover, in coinfection with both mating types, the MATα
strains more likely disseminate to the central nervous system which
might explain the prevalence among the clinical isolates40.
In conclusion, the results obtained in this study add new information
to the available data on molecular epidemiology of C. neoformans in
the southeast region of Brazil.
RESUMO
Genotipagem, sorotipagem e determinação de mating-type de
isolados clínicos de Cryptococcus neoformans do Estado de São
Paulo, Brasil
Cryptococcus neoformans, pertencente à classe dos basidiomicetos,
é um importante patógeno, principalmente em pacientes
imunocomprometidos. Neste estudo, 47 isolados clínicos de C.
neoformans de várias regiões do Estado de São Paulo foram avaliados
quanto aos sorotipos e ao mating-type por PCR. A diversidade genética
foi analisada por PCR-fingerprinting com a seqüência iniciadora
específica para regiões microssatélite (GACA)4, RAPD com o iniciador
6 (Amersham Pharmacia Biotech) e por RFLP do gene PLB1 digerido
com AvaI. Todos os isolados foram obtidos de pacientes HIV positivos
e identificados como sorotipo A e MATα. A maioria dos isolados
pertencia ao tipo molecular VNI (45/47) e apenas dois foram VNII
quando analisados por PCR-fingerprinting e PCR-RFLP.
Homogeneidade alta foi obtida com o iniciador (GACA)4, com a maioria
dos isolados apresentando correlação alta (> 0.9). Os resultados do
RAPD, por sua vez, revelaram maior heterogeneidade com número
maior de perfis moleculares. Por PCR-RFLP, nenhum tipo molecular
novo foi encontrado, realçando a idéia de que em genes conservados
como PLB1, as diferenças podem ser resultantes de divergências
evolutivas dentro do complexo C. neoformans, separando os isolados
nos oito subtipos moleculares já estabelecidos. Nossos resultados
fornecem novas informações sobre a epidemiologia molecular de C.
neoformans na região sudeste do Brasil.
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